3Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study [J]. Circulation, 2003, 107(23): 2920-2925.
4Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implica- tions for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study[J]. JAMA, 2001, 285(18): 2370-2375.
5Smit MD, Moes ML, Maass AH, et al. The importance of whether atrial fibrillation or heart failure develops first [J]. Eur J Heart Fail, 2012, 14(9): 1030-1040.
6Suzuki S, Sagara K, Otsuka T, et al. A new scoring sys- tem for evaluating the risk of heart failure events in Japanese patients with atrial fibrillation [J]. Am J Cardiol, 2012, 110(5): 678-682.
7Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation [J]. N Engl J Med, 2010, 362(15): 1363-1373.
8Rienstra M, Damman K, Mulder BA, et al. Beta-blockers and outcome in heart failure and atrial fibrillation [J]. JACC Heart Fail, 2013, 1(1): 21-28.
9Wbitbeek MG, Chamigo R J, Khairy P, et al. Increased mortality among patients taking digoxin--analysis from the AFFIRM study [J]. Eur Heart J, 2013, 34(20): 1481- 1488.
10Van Veldhuisen D J, Van Gelder IC, Ahmed A, et al. Digoxin for patients with atrial fibrillation and heart fail- ure: paradise lost or not? [J]. Eur Heart J, 2013, 34(20): 1468-1470.
